ESC 365 - Paclitaxel-coated Zilver PTX drug-eluting stent treatment does not result in increased long-term all-cause mortality compared to uncoated devices from Japan Post-Market Surveillance Study

ESC Premium Access

Paclitaxel-coated Zilver PTX drug-eluting stent treatment does not result in increased long-term all-cause mortality compared to uncoated devices from Japan Post-Market Surveillance Study

Session: Lower Extremity Artery Revascularization in 2020

Topic: Intervention

Speaker: Doctor H. Yokoi (Fukuoka, JP)

Event: ESC Congress 2020

Congress Presentation

Add to my library

About the speaker

Doctor Hiroyoshi Yokoi

Fukuoka Sanno Hospital, Fukuoka (Japan)

0 follower

1 more presentation in this session

TRIACCESS study: Randomized comparison between radial, femoral and transpedal access for for percutanous supertfitial femoral artery angioplasty

Speaker: Associate Professor Z. Ruzsa (Szeged, HU)

Access the full session

Lower Extremity Artery Revascularization in 2020

Speakers: Doctor H. Yokoi, Associate Professor Z. Ruzsa

About the event

ESC Congress 2020

29 August - 1 September 2020

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources